EUVIMEDEUVIMED entdecken
Crossref

Changes in Lean Muscle Mass, Muscle Strength, and Physical Performance Following First‐Line Chemotherapy in Patients With Lymphoma

Charlotte Nørregaard Grønset, Mary Jarden, Jan Christensen, Casper Simonsen, Anders Tolver, Charlotte Suetta iD, Martin Hutchings

Hematological Oncology · 2025

DOI: 10.1002/hon.70154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, 2025. Verfasst von Charlotte Nørregaard Grønset und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational Therapy and Physiotherapy, Centre of Head and Orthopedics, Copenhagen University Hospital - Rigshospitalet, Copenhagen, De…. Hauptthemen laut MEDLINE: Muscle Strength, Body Composition, Lymphoma, Physical Functional Performance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Rigshospitalet, Danske Fysioterapeuter.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymphomas are common cancers affecting the lymphatic system. Chemotherapy is a standard treatment, yet its impact on patient's physical capacity remains understudied. This study aimed to evaluate changes in body composition, muscle strength, and physical performance in patients diagnosed with lymphoma undergoing chemotherapy and to explore the potential association between muscle function and treatment tolerability. This single‐center prospective cohort study included participants aged ≥ 18 years scheduled for first‐line anthracycline‐based chemotherapy for aggressive lymphoma. Patients were recruited and tested before treatment and after 6 months. Body composition (DXA), hand‐grip strength, 30 s Sit‐To‐Stand test, 10‐m gait speed and Quality of Life (EORTC‐QLQ‐C30) were assessed. Low muscle strength, lean mass and gait speed were defined according to the European Working Group on Sarcopenia in Older People (EWGSOP2). Fifty‐eight patients (42 males) with a median age of 62 years (range 18–87) completed both test points and were included in the analysis. From baseline to follow‐up, total lean mass decreased by 1.70 kg (95% CI −2.55 to −0.85, p = 0.0002), body fat percentage increased by 2.3% (95% CI 1.19 to 3.41, p = 0.0001), handgrip strength decreased by 1.93 kg (95% CI −3.15 to −0.71, p = 0.002), whereas Sit‐To‐Stand performance increased by 1.4 repetitions (95% CI 0.15 to 2.69, p = 0.03). No changes were observed in appendicular lean mass, body weight, or gait speed. Further, there was no association between changes in muscle function and treatment tolerability. Significant declines in total lean body mass and muscle strength were observed from the start of chemotherapy to 6 months post treatment. These findings underscore the importance of routine muscle function screening and rehabilitation during and after chemotherapy for patients with lymphoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscle StrengthBody CompositionLymphomaPhysical Functional PerformanceMuscle, SkeletalAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleMiddle AgedAgedAdultAged, 80 and overAdolescentYoung AdultProspective StudiesQuality of LifeHand Strength

Stichwörter der Autor:innen

absorptiometryhand strengthmusclesneoplasmsphotonsarcopeniawalking speed

Autor:innen und Institutionen

  • Department of Occupational Therapy and Physiotherapy, Centre of Head and Orthopedics, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Department of Hematology, Center for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Centre for Physical Activity Research, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Danish Cancer Society, Statistics and Data Analysis, Copenhagen, Denmark.
  • Geriatric Research Unit, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.

ORCID-Profile: Charlotte Suetta

Förderung

  • Rigshospitalet
  • Danske Fysioterapeuter

Zitieren

APA

Grønset, C. N., Jarden, M., Christensen, J., Simonsen, C., Tolver, A., Suetta, C., & Hutchings, M. (2025). Changes in Lean Muscle Mass, Muscle Strength, and Physical Performance Following First‐Line Chemotherapy in Patients With Lymphoma. Hematological Oncology. https://doi.org/10.1002/hon.70154

Vancouver

Grønset CN, Jarden M, Christensen J, Simonsen C, Tolver A, Suetta C, et al. Changes in Lean Muscle Mass, Muscle Strength, and Physical Performance Following First‐Line Chemotherapy in Patients With Lymphoma. Hematological Oncology. 2025. doi:10.1002/hon.70154

BibTeX
@article{Grnset2025,
  author = {Grønset, Charlotte Nørregaard and Jarden, Mary and Christensen, Jan and Simonsen, Casper and Tolver, Anders and Suetta, Charlotte and Hutchings, Martin},
  title = {Changes in Lean Muscle Mass, Muscle Strength, and Physical Performance Following First‐Line Chemotherapy in Patients With Lymphoma},
  journal = {Hematological Oncology},
  year = {2025},
  doi = {10.1002/hon.70154}
}
Kostenlos starten →